ArticleFrontiers in immunology2025

Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer.

Meiling Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.